World Biomanufacturing Forum 2024 Concludes Successfully

Amsterdam, Netherlands – November 28, 2024 – The World Biomanufacturing Forum, organized by Leadvent Group, concluded today at the Steigenberger Airport Hotel in Amsterdam, Netherlands. 

The two-day event that took place on the 27th and 28th of November 2024 brought together global leaders, industry experts, researchers, and innovators to discuss the latest advancements and challenges in the field of biomanufacturing.

The forum featured a diverse range of topics, including:

  • Bioprocess intensification
  • Sustainable biomanufacturing
  • Next-generation biotechnologies
  • Regulatory landscape
  • The future of biomanufacturing

Attendees had the opportunity to participate in insightful keynote presentations, panel discussions, interactive workshops, and networking sessions. The event provided a platform to exchange knowledge, foster collaborations, and explore new opportunities in the biomanufacturing industry.

Key Highlights of the Event:

  • Keynote Presentations: Renowned experts delivered insightful presentations on cutting-edge topics like biocatalysis development, cell and gene therapy, and biomaterials.
  • Panel Discussions: Engaging panel discussions explored the challenges and opportunities in biomanufacturing, including regulatory hurdles, Cell Line Engineering, and supply chain risks.
  • Networking Opportunities: Attendees had the chance to connect with like-minded professionals, forge partnerships, and explore potential collaborations.

 

“We are thrilled with the success of the World Biomanufacturing Forum 2024,” said Max Fernandez, VP, Global Regulatory Affairs, Intellective Bio. “The event showcased the latest innovations and trends in the field, and we believe it has contributed significantly to advancing the biomanufacturing industry.”

For more information on Leadvent Group, please visit www. Leadventgrp.com.

Event detail: 

https://www.leadventgrp.com/events/world-biomanufacturing-forum/details

Contact:

Leadvent Group

[email protected]

+420 776 268 760

twitter